TY - JOUR
T1 - Distribution of double-negative (CD4- CD8-, DN) T subsets in blood and synovial fluid from patients with rheumatoid arthritis
AU - Liu, Ming Fei
AU - Yang, Chyun Yu
AU - Chao, Shan Chien
AU - Li, Jiann Shyong
AU - Weng, Tien Hsinng
AU - Lei, Huan Yao
PY - 1999/6/30
Y1 - 1999/6/30
N2 - Double-negative (CD4- CD8-) T (DNT) cells have been postulated to be potentially autoreactive. However, the role of DNT cells in rheumatoid arthritis (RA) has received limited attention. We investigated the distribution of DNT subsets in peripheral blood (PB) and synovial fluid (SF) from patients with active RA to determine whether these cells have relevance to RA. Two-colour flow cytometric analysis was performed to detect DNT cells in PB from 35 RA patients, 26 healthy controls and in SF aspirated from 19 inflamed rheumatoid joints. The subsets of DNT cells, i.e those expressing T cell receptor αβ (αβDNT) or γδ (γδDNT) were simultaneously examined. Our results showed that DNT cells constituted a very minor subset of PB lymphocytes. When expressed as a percentage of total lymphocytes, αβDNT levels in normal individuals ranged from 0.27 to 2.08% (average 0.76%), while those of γδDNT ranged from 1.02 to 11.42% (average 3.23%). Compared with normal individuals, RA patients had a similar distribution of αβDNT cells in both PB and SF. However, RA patients had significantly lower levels of γδDNT cells in PB than control subjects (1.38 ± 1.08% vs 3.23 ± 2.12%, p<0.05), while the levels of γδDNT cells in SF of RA patients were higher than those in PB from RA patients and normal controls. The difference between PB and SF in RA was statistically significant (3.90 ± 1.88% vs 1.38 ± 1.08%, p < 0.05). A higher level of γδDNT in SF than their paired PB was consistently noted from nine available paired samples. Our findings suggest that γδDNT cells, but not αβDNT cells, are probably relevant to RA. The lower percentage of circulating γδDNT cells might have resulted from migration from the circulation into the synovium, suggesting a role for γδDNT cells in the pathogenesis of rheumatoid synovitis.
AB - Double-negative (CD4- CD8-) T (DNT) cells have been postulated to be potentially autoreactive. However, the role of DNT cells in rheumatoid arthritis (RA) has received limited attention. We investigated the distribution of DNT subsets in peripheral blood (PB) and synovial fluid (SF) from patients with active RA to determine whether these cells have relevance to RA. Two-colour flow cytometric analysis was performed to detect DNT cells in PB from 35 RA patients, 26 healthy controls and in SF aspirated from 19 inflamed rheumatoid joints. The subsets of DNT cells, i.e those expressing T cell receptor αβ (αβDNT) or γδ (γδDNT) were simultaneously examined. Our results showed that DNT cells constituted a very minor subset of PB lymphocytes. When expressed as a percentage of total lymphocytes, αβDNT levels in normal individuals ranged from 0.27 to 2.08% (average 0.76%), while those of γδDNT ranged from 1.02 to 11.42% (average 3.23%). Compared with normal individuals, RA patients had a similar distribution of αβDNT cells in both PB and SF. However, RA patients had significantly lower levels of γδDNT cells in PB than control subjects (1.38 ± 1.08% vs 3.23 ± 2.12%, p<0.05), while the levels of γδDNT cells in SF of RA patients were higher than those in PB from RA patients and normal controls. The difference between PB and SF in RA was statistically significant (3.90 ± 1.88% vs 1.38 ± 1.08%, p < 0.05). A higher level of γδDNT in SF than their paired PB was consistently noted from nine available paired samples. Our findings suggest that γδDNT cells, but not αβDNT cells, are probably relevant to RA. The lower percentage of circulating γδDNT cells might have resulted from migration from the circulation into the synovium, suggesting a role for γδDNT cells in the pathogenesis of rheumatoid synovitis.
UR - http://www.scopus.com/inward/record.url?scp=0033026224&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0033026224&partnerID=8YFLogxK
U2 - 10.1007/s100670050089
DO - 10.1007/s100670050089
M3 - Article
C2 - 11206348
AN - SCOPUS:0033026224
VL - 18
SP - 227
EP - 231
JO - Clinical Rheumatology
JF - Clinical Rheumatology
SN - 0770-3198
IS - 3
ER -